These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3618995)

  • 1. Failure of critically ill patients to metabolise midazolam.
    Shelly MP; Mendel L; Park GR
    Anaesthesia; 1987 Jun; 42(6):619-26. PubMed ID: 3618995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.
    Boulieu R; Lehmann B; Salord F; Fisher C; Morlet D
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):255-8. PubMed ID: 9725490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?
    Franken LG; Masman AD; de Winter BCM; Baar FPM; Tibboel D; van Gelder T; Koch BCP; Mathot RAA
    Br J Clin Pharmacol; 2017 Aug; 83(8):1701-1712. PubMed ID: 28177137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of midazolam in critically ill pediatric patients.
    Nahara MC; McMorrow J; Jones PR; Anglin D; Rosenberg R
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):219-21. PubMed ID: 11420893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients--preliminary results.
    Dirksen MS; Vree TB; Driessen JJ
    Anaesth Intensive Care; 1987 Nov; 15(4):440-4. PubMed ID: 3122596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
    Malacrida R; Fritz ME; Suter PM; Crevoisier C
    Crit Care Med; 1992 Aug; 20(8):1123-6. PubMed ID: 1643892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midazolam disposition in patients undergoing continuous venovenous hemodialysis.
    Bolon M; Bastien O; Flamens C; Paulus S; Boulieu R
    J Clin Pharmacol; 2001 Sep; 41(9):959-62. PubMed ID: 11549100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetic monitoring of midazolam in critically ill patients.
    Spina SP; Ensom MH
    Pharmacotherapy; 2007 Mar; 27(3):389-98. PubMed ID: 17316150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients.
    Kirwan CJ; Lee T; Holt DW; Grounds RM; MacPhee IA; Philips BJ
    Intensive Care Med; 2009 Jul; 35(7):1271-5. PubMed ID: 19198803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children.
    Vet NJ; Brussee JM; de Hoog M; Mooij MG; Verlaat CW; Jerchel IS; van Schaik RH; Koch BC; Tibboel D; Knibbe CA; de Wildt SN;
    Am J Respir Crit Care Med; 2016 Jul; 194(1):58-66. PubMed ID: 26796541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
    Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
    J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of prolonged sedation using flumazenil in critically ill patients.
    Bodenham A; Park GR
    Anaesthesia; 1989 Jul; 44(7):603-5. PubMed ID: 2505628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What changes drug metabolism in critically ill patients?--II Serum inhibits the metabolism of midazolam in human microsomes.
    Park GR; Miller E; Navapurkar V
    Anaesthesia; 1996 Jan; 51(1):11-5. PubMed ID: 8669558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
    Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
    Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing sedative infusion from propofol to midazolam improves sublingual microcirculatory perfusion in patients with septic shock.
    Penna GL; Fialho FM; Kurtz P; Japiassú AM; Kalichsztein M; Nobre G; Villela NR; Bouskela E
    J Crit Care; 2013 Oct; 28(5):825-31. PubMed ID: 23683563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.
    Andersen V; Pedersen N; Larsen NE; Sonne J; Larsen S
    Br J Clin Pharmacol; 2002 Aug; 54(2):120-4. PubMed ID: 12207630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midazolam for continuous sedation in Japanese critical care patients: phase II study.
    Kinoshita K; Sakurai A; Mera K; Shirai K; Hone J; Moriya T; Okuno K; Noda E; Yoshida S; Kaburagi M; Kashiwa M; Imai Y; Tanjoh K; Hayashi N
    J Int Med Res; 2001; 29(4):342-8. PubMed ID: 11675908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged sedation with midazolam in critically ill patients undergoing artificial ventilation].
    Castillo J; Bisbe E; Sierra P; Escolano F; Castaño J
    Rev Esp Anestesiol Reanim; 1995 Oct; 42(8):303-5. PubMed ID: 8560048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.